Search
Transcode Therapeutics Inc
RNAZAdd to Watchlist
6.210USD
+0.970+18.51%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
5.90MMarket Cap
LossP/E TTM
Transcode Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-52.59
96.02%
Analyst Rating
2025-05-07
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its current assets were 21.98M, with a year-on-year change of 209.92.
What are the total assets of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its total assets of Transcode Therapeutics Inc were 162.40M, with a year-on-year change of 2126.32.
What are the total liabilities of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its total liabilities of Transcode Therapeutics Inc were 10.52M, with a year-on-year change of 12.94.
What is the total equity of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its total equity of Transcode Therapeutics Inc was 151.88M, with a year-on-year change of 7623.53.
What is the net investment of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its net investment of Transcode Therapeutics Inc was -4.44K, with a year-on-year change of 79.61.
What is the net financing of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its net financing of Transcode Therapeutics Inc was 31.52M, with a year-on-year change of 92.20.
What is the Earnings Per Share (EPS) of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -52.59, with a year-on-year change of 96.02.
What is the Return on Assets (ROA) of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -40.85, with a year-on-year change of 84.81.
What is the operating profit of Transcode Therapeutics Inc?
According to Transcode Therapeutics Inc's FY2025 earnings report, its operating profit was -17.92M, with a year-on-year change of -18.36.